Gastrin-releasing peptide as a molecular target for inflammatory diseases: an update
- PMID: 23621446
- DOI: 10.2174/1871528111312030003
Gastrin-releasing peptide as a molecular target for inflammatory diseases: an update
Abstract
Gastrin-releasing peptide (GRP) is a neuropeptide that acts through G protein coupled receptors and is involved in signal transmission in both the central and peripheral nervous systems. Its receptor, gastrin-releasing peptide receptor (GRPR), is expressed by various cell types, and it is overexpressed in cancer cells. In recent years, studies have suggested the relationship of GRP and inflammatory diseases. RC-3095, a selective GRPR antagonist, was found to have antiinflammatory properties in models of arthritis, gastritis, uveitis and sepsis. Furthermore, GRP mediates air pollutioninduced airway hyperreactivity and airway inflammation in mice. In conclusion, GRP and its receptor are relevant to the inflammatory response, being a potential therapeutic target several diseases are related to inflammation.
Similar articles
-
Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils.Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):547-52. doi: 10.1073/pnas.1110996109. Epub 2011 Dec 27. Proc Natl Acad Sci U S A. 2012. PMID: 22203955 Free PMC article.
-
Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice.Laryngoscope. 2018 Nov;128(11):E377-E384. doi: 10.1002/lary.27394. Epub 2018 Aug 27. Laryngoscope. 2018. PMID: 30151920
-
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.Cancer Lett. 2001 Sep 28;171(1):37-45. doi: 10.1016/s0304-3835(01)00543-2. Cancer Lett. 2001. PMID: 11485826
-
Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications.Curr Drug Targets. 2016;17(5):508-14. doi: 10.2174/1389450116666151001112130. Curr Drug Targets. 2016. PMID: 26424393 Review.
-
Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases.Inflamm Allergy Drug Targets. 2007 Dec;6(4):197-200. doi: 10.2174/187152807783334319. Inflamm Allergy Drug Targets. 2007. PMID: 18220954 Review.
Cited by
-
Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.PLoS One. 2016 Jan 25;11(1):e0147500. doi: 10.1371/journal.pone.0147500. eCollection 2016. PLoS One. 2016. PMID: 26807730 Free PMC article.
-
Insights into bombesin receptors and ligands: Highlighting recent advances.Peptides. 2015 Oct;72:128-44. doi: 10.1016/j.peptides.2015.04.026. Epub 2015 May 11. Peptides. 2015. PMID: 25976083 Free PMC article. Review.
-
Signalling and putative therapeutic molecules on the regulation of synoviocyte signalling in rheumatoid arthritis.Bone Joint Res. 2021 Apr;10(4):285-297. doi: 10.1302/2046-3758.104.BJR-2020-0331.R1. Bone Joint Res. 2021. PMID: 33890482 Free PMC article.
-
Gastrin-releasing peptide receptor antagonist RC-3095 inhibits Porphyromonas gingivalis lipopolysaccharide-accelerated atherosclerosis by suppressing inflammatory responses in endothelial cells and macrophages.Inflamm Res. 2024 Nov;73(11):1833-1846. doi: 10.1007/s00011-024-01934-0. Epub 2024 Aug 20. Inflamm Res. 2024. PMID: 39164592
-
Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis.Mol Ther. 2023 Sep 6;31(9):2734-2754. doi: 10.1016/j.ymthe.2023.06.016. Epub 2023 Jul 5. Mol Ther. 2023. PMID: 37415332 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
